64.46MMarket Cap
LossP/E TTM
Elicio Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Elicio Therapeutics Inc is 5.76, ranking 358 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.18, which is -1419.40% below the recent high of 15.60 and -430.36% above the recent low of -6.27.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.